文献速递临床微生物分子诊断

新冠疫情前后成人呼吸道感染病原菌及耐药谱变化:7年回顾性分析

Shifts in bacterial pathogen and resistance spectra of adult respiratory tract infections before vs. after the COVID-19 pandemic: A 7-year retrospective data analysis.
PubMed 文献 · Clin Chim Acta · 2026-05-28

该研究回顾分析2018至2024年49,260份成人呼吸道标本,比较疫情前、中、后三个时期病原菌分布与耐药性变化。结果显示病原菌阳性率从18.60%降至14.34%后部分回升至15.99%,肺炎克雷伯菌占比从27.33%升至41.16%,多种抗菌药物耐药率在疫情期间短暂下降后反弹至或超过疫情前水平。

要点

  • 肺炎克雷伯菌占比从27.33%升至41.16%,成为优势病原菌。
  • 鲍曼不动杆菌和铜绿假单胞菌碳青霉烯耐药率持续高于60%。
  • 多种药物耐药率疫情后反弹至或超过疫情前基线水平。

核心结论

  • 新冠疫情对呼吸道病原菌生态的干扰是暂时的,疫情后肺炎克雷伯菌优势巩固、非发酵菌碳青霉烯耐药持续高位、多种药物耐药率反弹。

研究设计与样本

  • 回顾性分析2018至2024年49,260份成人呼吸道标本,分为疫情前(2018-2019)、疫情期间(2020-2022)和疫情后(2023-2024)三期。

主要发现

  • 总体病原菌阳性率从疫情前18.60%降至疫情期间14.34%,疫情后部分回升至15.99%。
  • 季节性变异减弱,尤其夏季阳性率受抑制。
  • 肺炎克雷伯菌占比从27.33%升至41.16%,优势地位巩固。
  • 疫情期间鲍曼不动杆菌占比短暂升至14.70%,之后下降。
  • 多种关键抗菌药物耐药率疫情期间短暂下降,随后反弹至或超过疫情前基线。

临床怎么用

  • 需持续开展本地病原菌及耐药监测。
  • 应加强抗菌药物管理以应对耐药率反弹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the impact of the COVID-19 pandemic on the distribution and antimicrobial resistance (AMR) patterns of common bacterial pathogens isolated from respiratory specimens in adults. METHODS: We analyzed 49,260 adult respiratory tract specimens collected between 2018 and 2024, dividing them into pre-pandemic (2018-2019), pandemic (2020-2022), and post-pandemic (2023-2024) periods. We focused on shifts in seasonal patterns, the relative abundance of five key pathogens (Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus), and changes in their antimicrobial susceptibility profiles. RESULTS: The overall pathogen positivity rate dropped from 18.60% pre-pandemic to 14.34% during the pandemic, with only a partial recovery to 15.99% afterwards. Seasonal variation was attenuated, particularly with suppressed summer rates. K. pneumoniae solidified its position as the dominant pathogen, increasing from 27.33% to 41.16% of isolates. The pandemic period saw a transient surge in A. baumannii (14.70%), which later declined. More critically, we observed a clear "rebound effect" in AMR: resistance rates to several key antimicrobials fell temporarily during the pandemic but subsequently rose to meet or exceed pre-pandemic baselines. Carbapenem resistance in A. baumannii and P. aeruginosa remained critically high (>60%). CONCLUSION: Our data indicate that the pandemic's disruptive effects on respiratory pathogen ecology were temporary. The post-pandemic era is characterized by a consolidating dominance of K. pneumoniae, persistently high carbapenem resistance in non-fermenters, and a rebound in resistance rates for many drugs. These trends reinforce the need for continuous local surveillance and rigorous antimicrobial stewardship.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Li Y, Ge J, Yang M, et al. Shifts in bacterial pathogen and resistance spectra of adult respiratory tract infections before vs. after the COVID-19 pandemic: A 7-year retrospective data analysis. Clin Chim Acta. 2026. PMID: 42214741. doi:10.1016/j.cca.2026.121120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。